Second, we have not yet developed a drug delivery strategy that can specifically target kallistatin/Serpina3c within adipocytes, with the aim of providing new options for translational research in obesity treatment. This evidence concerns the gene SERPINA4 and obesity due to melanocortin 4 receptor deficiency.